Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: MED STOP PHARMACEUTICALS INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-07 to 2024-03-18
Current total value of award: $2579.5
Description: 8510492271!MOXIFLOXACIN HYDROC